Opinion

Video

Preventing RSV in Adults: Current Vaccination Options

Panelists compare the currently available RSV vaccines for adults, considering their target populations, dosing, and administration to prevent RSV infection.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
1 expert in this video
Related Content
RSV Respiratory syncytial virus vaccine vial on laboratory table with scientific research background - Image credit: AiDesign | stock.adobe.com
September 16th 2025

RSV Immunization Shows Cardiorespiratory Benefits in Adults Aged 60 and Older

Kennedy Ferruggia, Assistant Editor
pharmacy focus oncology edition
September 16th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Doctor making a vaccination - Image credit: guerrieroale | stock.adobe.com
September 16th 2025

New Clinical Guidance Recommends Vaccines to Protect Cardiovascular Patients From Respiratory Illness

Kennedy Ferruggia, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
September 16th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Abrysvo RSV vaccine, Respiratory Syncytial Virus vaccination for pregnant women, Australian immunisation program 2025, Queensland General PracticeImage credit: Cynthia | stock.adobe.com
September 16th 2025

RSVpreF Vaccine Is Well-Tolerated in Adults, Demonstrating Favorable Safety Profile

Kennedy Ferruggia, Assistant Editor
RSV vaccine vial with syringe - Respiratory syncytial virus shot - Image credit: MargJohnsonVA | stock.adobe.com
September 16th 2025

RSV Vaccine Uptake Remains Low Among US Adults 60 Years and Older

Kennedy Ferruggia, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.